Your session is about to expire
← Back to Search
MOD-INT for Insulin Resistance (HI-PACE Trial)
N/A
Waitlist Available
Led By Damon L Swift, Ph.D.
Research Sponsored by East Carolina University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Body mass index 30-45 kg/m2
sedentary/low active (step count ≤ 6,500 step/day)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 24 weeks
Awards & highlights
HI-PACE Trial Summary
African Americans are at a substantially greater type 2 diabetes risk compared to Caucasians; however, very little data are available on the effects of exercise training on type 2 diabetes risk factors in at risk African Americans. The present proposal will evaluate the effects of 6 months of moderate versus vigorous intensity aerobic exercise training on fitness, insulin sensitivity, mitochondrial capacity, skeletal muscle oxidative/insulin sensitivity markers, adiposity, and quality of life in African Americans.
Eligible Conditions
- Insulin Resistance
- Obesity
- Sedentary Lifestyle
HI-PACE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHI-PACE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in cardiorespiratory fitness
Secondary outcome measures
Change in arterial stiffness
Change in body composition
Change in body weight
+8 moreHI-PACE Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: MOD-INTExperimental Treatment1 Intervention
The Moderate intensity exercise training (MOD-INT) group will exercise at a moderate aerobic exercise intensity for 24 weeks
Group II: HIGH-INTExperimental Treatment1 Intervention
High Intensity exercise training (HI-INT) group will exercise at a high aerobic intensity for 24 weeks
Group III: ControlActive Control1 Intervention
This group does not change physical activity during the intervention period, but will receive exercise training after the study is complete
Find a Location
Who is running the clinical trial?
East Carolina UniversityLead Sponsor
107 Previous Clinical Trials
38,749 Total Patients Enrolled
1 Trials studying Insulin Resistance
39 Patients Enrolled for Insulin Resistance
Damon L Swift, Ph.D.Principal InvestigatorEast Carolina University
2 Previous Clinical Trials
84 Total Patients Enrolled
1 Trials studying Insulin Resistance
39 Patients Enrolled for Insulin Resistance
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger